Quantum-Si Incorporated - Ordinary Shares - Class A Stock News

Quantum-Si incorporated ( QSI ) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Risa Lindsay Jeffrey Hawkins - President, CEO & Director Jeffry Keyes - CFO & Treasurer Conference Call Participants Alexander Vukasin - Canaccord Genuity Corp., Research Division Scott Henry - Alliance Global Partners, Research Division Swayampakula Ramakanth - H.C. Wainwright & Co, LLC, Res...

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports Third Quarter 2025 Financial Results. Announces Successful Sequencing on Prototype Proteus Unit, Development Program is On-Track.

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum.

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025.

Quantum-Si's (QSI -4.02%) shares weren't quite the picture of health as the trading week came to an end. Investors, concerned about the healthcare technology company potentially making dilutive secondary share issues, traded out of the stock to leave it with a nearly 5% loss on the day.

BRANFORD, Conn--(BUSINESS WIRE)--Quantum-Si to Host Investor & Analyst Event in New York City on November 19, 2025.

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces the Launch of V4 Sequencing Kit, Expanding Proteome Coverage and Unlocking New Applications for Protein Sequencing.